Delivery Order SPE2DE21D7009-SPE2D626F71HP
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $26,980 fixed-price delivery order with economic price adjustment on November 28, 2025, under contract 4570237140 for pain management medical devices and services. The order, with an ultimate completion date of December 5, 2025, represents work to be performed in Valencia, California, and is funded by the Defense Logistics Agency's Medical Supply Chain division. This delivery order is issued under the...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a $31,771.22 fixed-price delivery order with economic price adjustment for pain management medical devices on August 6, 2025, with completion targeted for August 13, 2025. The award was issued without set-aside designation by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense. Work will be performed in Valencia, California. This delivery order represents...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a fixed-price delivery order valued at $43,709.82 on December 15, 2025, for pain management medical devices and equipment. The delivery order, with a ultimate completion date of December 22, 2025, will be performed in Valencia, California, and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-related procurement entity within the Department of Defense. This award carries no small...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $40,769.27 fixed price delivery order with economic price adjustment for pain management medical devices on December 19, 2025, with an ultimate completion date of December 29, 2025. The contract is funded by the Medical Supply Chain, a defense-related procurement entity, and performance will be conducted in Valencia, California. This delivery order represents work issued under Boston Scientific...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $1,867.00 fixed-price delivery order with economic price adjustment on November 28, 2025, for pain management medical devices and services. The contract, identified as PAIN MANAGEMENT (4570238376), is set to be completed by December 5, 2025, with performance occurring in Valencia, California. This delivery order was funded by the Medical Supply Chain, a defense-related procurement entity, and represents...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,771.22 for pain management medical devices on November 28, 2025, under a Defense Logistics Agency Troop Support Medical contract. The delivery order, which is fixed-price with economic price adjustment provisions and carries an ultimate completion date of December 5, 2025, represents a task order against the company's larger indefinite delivery contract (SPE2DE)...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $43,709.82 fixed-price delivery order with economic price adjustment on December 15, 2025, for pain management medical devices and related services. The delivery order, which is part of the larger SPE2DE indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical branch valued at $83.1 million through August 2026, carries no small business set-aside designation. Work...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F71HPDelivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a $31,798.00 fixed-price delivery order with economic price adjustment for pain management medical devices, awarded December 31, 2025, with an ultimate completion date of March 2, 2026. This delivery order, issued without a small business set-aside, is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the contractor's Valencia, California facility. The award represents a task order against Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) valued at $83.1 million with DLA Troop Support Medical, which expires August 16, 2026. Boston Scientific Neuromodulation specializes in advanced neuromodulation therapies and non-opioid pain management solutions, including spinal cord stimulation systems, implantable pain pumps, and radiofrequency ablation devices. The company has demonstrated consistent performance delivering pain management technologies to military treatment facilities and Veterans Affairs medical centers nationwide. This delivery order supports the Department of Defense's objective to provide service members and veterans with innovative alternatives to opioid-based pain management for chronic pain resulting from traumatic injuries, leveraging Boston Scientific's proprietary RestoreSensor and Spectra WaveWriter spinal cord stimulation systems along with associated accessories, training, and technical support services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.8k | 12/30/25 |